U.S. Biotechs Are Keeping More Secrets to Beat Copycats in China
Western biotechs are getting a new playbook with tighter controls to stay ahead of an ultraefficient pharmaceutical pipeline overseas.
Connecting Global Economies
Western biotechs are getting a new playbook with tighter controls to stay ahead of an ultraefficient pharmaceutical pipeline overseas.